Showing results (1611-1620 of 2,586) with videos related to

Sort By:
Pageof 259
Molecular Oncology|September 2, 2022
Growth arrest-specific protein 2 (GAS2) interacts with CXCR4 to promote T-cell leukemogenesis partially via c-MYCWenjuan Ma, Yan Wan, Jianxiang Zhang, et al.
Molecular Oncology|December 26, 2021
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort studyMarine Jary, Wen-Wei Liu, Dongyao Yan, et al.
Molecular Oncology|November 24, 2023
A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomasMalay K Sannigrahi, Austin C Cao, Pavithra Rajagopalan, et al.
Molecular Oncology|December 23, 2023
Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023Ulrik Ringborg, Joachim von Braun, Julio Celis, et al.
Molecular Oncology|December 23, 2023
NCI677397 targeting USP24-mediated induction of lipid peroxidation induces ferroptosis in drug-resistant cancer cellsShao-An Wang, Yu-Chih Wu, Feng-Ming Yang, et al.
Molecular Oncology|December 17, 2023
A newly identified 45-kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistanceSivahari Prasad Gorantla, Tony Andreas Mueller, Corinna Albers-Leischner, et al.
Molecular Oncology|February 28, 2024
PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanomaAjit Roy, Arup R Chakraborty, Melvin L DePamphilis
Molecular Oncology|August 26, 2024
APOBEC3C-mediated NF-κB activation enhances clear cell renal cell carcinoma progressionNora Hase, Danny Misiak, Helge Taubert, et al.
Molecular Oncology|May 25, 2024
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targetsEmilia Alors-Pérez, Ricardo Blázquez-Encinas, María Trinidad Moreno-Montilla, et al.
Molecular Oncology|May 21, 2024
Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expressionHung-Rong Yen, Wen-Chieh Liao, Chia-Hua Chen, et al.
Pageof 259